Next Article in Journal
Application of Exogenous Silicon for Alleviating Photosynthetic Inhibition in Tomato Seedlings under Low−Calcium Stress
Next Article in Special Issue
Assessment of the Antibiofilm Performance of Chitosan-Based Surfaces in Marine Environments
Previous Article in Journal
Comparative Transcriptome Analysis Identifies Key Defense Genes and Mechanisms in Mulberry (Morus alba) Leaves against Silkworms (Bombyx mori)
Previous Article in Special Issue
Serratiopeptidase Affects the Physiology of Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

The Assessment of Activity of Antiseptic Agents against Biofilm of Staphylococcus aureus Measured with the Use of Processed Microscopic Images

1
Nutrikon, KCZ Surgical Ward, 47-300 Krapkowice, Poland
2
Department of Environment Hygiene and Animal Welfare, Wroclaw University of Environmental and Life Sciences, 25 C.K. Norwida St., 51-630 Wroclaw, Poland
3
Department of Microbiology and Biotechnology, Faculty of Biotechnology and Animal Husbandry, West Pomeranian University of Technology in Szczecin, Piastów 45, 70-311 Szczecin, Poland
4
Bioimaging Laboratory, Łukasiewicz Research Network—PORT Polish Center for Technology Development, 54-066 Wrocław, Poland
5
Laboratory of Microbiology, Łukasiewicz Research Network–PORT Polish Center for Technology Development, 54-066 Wrocław, Poland
6
Department of Microbiology, Institute of Genetics and Microbiology, University of Wrocław, Stanisława Przybyszewskiego 63, 51-148 Wrocław, Poland
7
Department of Microbiology, Faculty of Medicine, Wroclaw Medical University, 50-368 Wroclaw, Poland
8
Department of Pharmaceutical Microbiology and Parasitology, Faculty of Pharmacy Wrocław Medical University, 50-556 Wrocław, Poland
9
Faculty of Medicine, Lazarski University, 02-662 Warszawa, Poland
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2022, 23(21), 13524; https://doi.org/10.3390/ijms232113524
Submission received: 21 October 2022 / Revised: 31 October 2022 / Accepted: 3 November 2022 / Published: 4 November 2022
(This article belongs to the Special Issue Mechanisms in Biofilm Formation, Tolerance and Control)

Abstract

:
Staphylococcal biofilms are major causative factors of non-healing wound infections. Their treatment algorithms recommend the use of locally applied antiseptic agents to counteract the spread of infection. The efficacy of antiseptics against biofilm is assessed in vitro by a set of standard quantitative and semi-quantitative methods. The development of software for image processing additionally allowed for the obtainment of quantitative data from microscopic images of biofilm dyed with propidium iodine and SYTO-9 reagents, differentiating dead cells from live ones. In this work, the method of assessment of the impact of antiseptic agents on staphylococcal biofilm in vitro, based on biofilms’ processed images, was proposed and scrutinized with regard to clinically relevant antiseptics, polyhexanide, povidone–iodine and hypochlorite. The standard quantitative culturing method was applied to validate the obtained data from processed images. The results indicated significantly higher activity of polyhexanide and povidone–iodine than hypochlorite against staphylococcal biofilm. Taking into account the fact that in vitro results of the efficacy of antiseptic agents against staphylococcal biofilm are frequently applied to back up their use in hospitals and ambulatory units, our work should be considered an important tool; providing reliable, quantitative data in this regard.

1. Introduction

Biofilms are aggregated communities of microbes embedded within an extracellular matrix, consisting of various molecules (carbohydrate polymers, exocellular DNA, proteins). A biofilm is considered highly tolerant to antiseptics, antibiotics and the immune system, not only due to the protective functions of matrix, but also due to the high concentration of cells within a relatively small surface and the differentiation of the cells’ metabolism/growth with regard to their spatial location [1]. Biofilms may be responsible for the chronic nature or persistence of the plethora of disease entities, including non-healing wounds. Biofilms treated improperly in such skin and soft tissue discontinuities increase the risk of limb amputation or even the patient’s death [2]. Staphylococci (Staphylococcus aureus, mainly) are bacteria with a particularly high ability to cause biofilm-based infections of non-healing wounds [3]. The present algorithms of treatment of these disease entities recommend (together with the debridement and application of dressings) the use of antiseptics, which are locally-applied antimicrobial liquids [4,5,6]. The first stage of assessment of antiseptics’ efficacy against biofilm-forming pathogens involves in vitro analyses. Their performance (together with toxicity studies) is necessary before any antiseptic can be used in clinical conditions. For these in vitro analyses, quantitative culturing of staphylococcal cells and colorimetric (semi-quantitative) methods are mostly applied. The data obtained by these methods are frequently supported by microscopic images (of qualitative character) from confocal/epifluorescence microscopy, in which, viable and compromised biofilm-forming cells are visualized with, among others, “Live/Dead” dyes [7,8,9]. The emergence of computational software for image processing allowed for the extraction of quantitative data from such types of microscopic images [10]. The aforementioned Live/Dead dyeing, visualized with the use of microscopy and analyzed with image processing software is presently considered a reliable toolbox for determination of antimicrobial (and anti-biofilm) efficacy. Its level should correlate with an increase in the red fluorescence signal from the Propidium Iodide dye (PI, “Dead”), binding to non-altered cells, and/or drop in the green fluorescence signal from the SYTO-9 dye (“Live”), binding to the altered (damaged) cells. Such changes, recorded by means of image processing software, can be further extracted into numerical values and analyzed with the use of statistical methods [11]. Nevertheless, the impact of phenomena taking place during biofilm culturing, introducing of antiseptic and dyeing of the biofilm samples, is frequently not taken into account in analysis of the image’s quantitative data on antibiofilm efficacy. This leads to discrepancies in the outcomes obtained, and the use of biofilm images as a sort of ornamental result (supporting quantitative data from culturing or colorimetric methods). In turn, we hypothesized that by analysis of these phenomena and application of image processing software, the information on such crucial parameters of biofilms treated with antiseptic, such as change of their confluency, thickness and ratio of live to dead cells can be properly extracted and perceived as data of at least equal value to the data obtained by the aforementioned classical methods. Therefore, we decided to address the above-mentioned issues and to increase the usability of confocal/epifluorescent microscopy in biofilm studies by provision of formula which allows for the use of data from microscopic images, and for calculation of the antibiofilm effectiveness of the given antiseptic. Specifically, the three antiseptic products, broadly applied in the clinical setting, were used in this research—polyhexanide, povidone–iodine and hypochlorous solution, because of their different mechanisms of action toward biofilms and biofilm-forming cells [12,13]. Being fully aware of the fact that an excessive number of variables included in the analysis may lead to data overload, resulting in their misinterpretation, we decided to scrutinize only staphylococcal biofilm (and not biofilm of other potentially relevant species) and its tolerance/sensitivity to these three antiseptics. Therefore, the two specific goals of the present study were to analyze the phenomena occurring in the range of microscopic and molecular interactions during biofilm culturing, introduction of antiseptic and dyeing with L/D, and to use this knowledge to establish a method for valid assessment (by means of microscopic and image processing methods) of the impact of antiseptics on biofilm in vitro.

2. Results

Not only the antiseptic, but also the antecedent sample’s preparation (rinsing) and subsequent dyeing procedures have an impact on the biofilm spatial structure. To develop a formula that can reliably assess the antiseptic efficacy (and includes impact of rinsing and dyeing), the main characteristics of the staphylococcal biofilm cultured in the in vitro setting was firstly analyzed.
Observed from the aerial perspective, the topography of staphylococcal biofilm in vitro resembled a hilly landscape (Figure 1A). The spatial concentration of cells within this structure was non-equal (for example, lower in parts “1” than in parts “2” and “3,” Figure 1B), what was manifested by uneven intensity of fluorescence signal from dyed cells in the particular fields of vision. The staphylococcal biofilm, cultured in the microplate setting, was also of a highly confluent character, i.e., biofilm-forming cells covered basically the whole surface of the plate’s wells (Figure 1B). The average level of confluency recorded for the 10 different staphylococcal biofilms, cultured in wells of 24-well plate, was 93.6 ± 5.5% (Table S1).
The application of confocal microscopy provided a more detailed insight into the distribution of staphylococcal cells (and their state) within the Z-axis (thickness) of biofilm structure. The staphylococcal biofilms, such as the one presented in Figure 2, were of hill-like shape and contained regions of different thickness and of different cells’ density, including areas non-covered with cells (“holes”).
The cellular density of biofilms, along the Z-axis, was higher in their middle (M) parts than in the top (T) and the bottom (B) parts (Figure 3). In turn, the cellular density of the T and B parts were comparable. Such observation was recorded for 100% (n = 10) biofilms formed by analyzed strains (Table S2).
With regard to the ratio of altered (damaged) to non-altered (non-damaged) cells within particular parts (B,M,T) of 10 staphylococcal biofilms, the three various patterns were distinguished (Figure S1). In 50% of cases, the majority of altered cells were located in the B part of the biofilms, while the majority of non-altered cells in their T part. In case of the second pattern, present in 30% of staphylococcal biofilms, the majority of altered cells were also localized in the B part of the biofilm, while the M and T parts consisted of the altered and non-altered cells in various proportions. In the case of the third pattern, present in 20% of staphylococcal biofilms, the majority of the non-altered cells were localized in the M part of the biofilm, while the remaining parts (T, B) of this structure consisted mostly of altered (damaged) cells (Table S2). These types of different cell distributions could also occur simultaneously within a single culture plate well (Figure S2). Next, the areas described in this manuscript as “the holes” (black, non-fluorescent areas pointed as “1s” in Figure 1B) were scrutinized. As already shown, the standard in vitro culture of staphylococci led to the formation of a biofilm of almost full confluency (average above 90%, Table S1). The lowest confluency (81.7%) among the tested strains was displayed by the S1 strain. For the biofilm of this strain, an analysis aiming to evaluate the character of the black, non-fluorescent areas was performed using L/D dyeing (Figure 4).
The analysis revealed that “holes” are areas non-covered with cells or covered with the DNA-containing debris (the distribution of PI within holes was uniform, with no signs of remaining cellular, oval shapes, Figure 4). Next, the analyses of biofilm thickness (understood as number of dyed cells along the Z axis) were performed from the point where the fluorescence level started to be detectable (the T part of biofilm) to the point where the fluorescence level was equal to the threshold (value of fluorescence recorded for an un-dyed sample) level, i.e., to the area where the biofilm ended and the polystyrene surface of the microplate began. The measured thickness of staphylococcal biofilms differed not only between particular strains, but also within a single sample (biofilm cultured in the particular well of a 24-well microplate) (Figure 5).
It was also observed that there was no direct correlation between biofilm thickness and intensity of measured fluorescence, which means that a specific biofilm could contain thinner areas where the fluorescence level was higher than it was in the specific, thicker areas (Table 1).
The specification of the main characteristic features (thickness, L/D cells ratio, confluency) of staphylococcal biofilms in vitro, summarized in Table 2, was necessary to analyze changes of these features after antiseptic introduction and the subsequent dyeing process.
The introduction and removal of liquids (rinsing, antiseptic introduction, dyeing) to and from the culture vessels, where biofilms are cultured, belong to the recognized disadvantages of microplate-based methods, as they lead to random de-attachment of biofilm. Figure 6 presents the impact of a single step (medium removal) on the spatial distribution of the staphylococcal biofilm during 90 s of observation. The processing of the initial (15 s) and the final image frame (90 s) with the use of imageJ software indicated (Figure 6, lower panel) that areas covered with cellular structures differed by 23.027%.
The process of rinsing is of paramount importance not only due to the impact on the staphylococcal biofilm structure and confluency, but also because it correlates with an uneven change in the fluorescence intensity level measured for SYTO-9 (“live”) and PI (“dead”) cells. As can be seen in Figure 7, the subsequent rinsing steps lead to a significantly stronger reduction of the PI fluorescence level compared to the reduction in the SYTO-9 fluorescence level.
Another variable, important from the view of coherence of results obtained, is that of operator-related character, as shown in Figure S3 and summarized in the Table 3. Based on the data collected in Table 2 and Table 3, the proper conclusions can be drawn from the images of non-treated biofilms (control group) and biofilms treated with antiseptic, such as those presented in Figure 8.
The non-treated biofilm (Figure 8, left picture) is almost fully confluent, (contrary to the treated-one), nevertheless, it contains regions of differentiated cellular density, manifested by differentiated levels of fluorescence within specific regions of observation (i.e., of more and less intense green color).
In turn, a high proportion of the image of treated biofilm is covered with black, non-fluorescent areas. The intensity of signal from SYTO-9-dyed cells is lower than in the case of non-treated biofilm. Thus, the main differences observed between the two pictures in Figure 8 are: (i) drop in confluency of treated biofilm and (ii) drop in the fluorescence level in treated biofilm compared to the non-treated one. The drop in confluency, as well as in the fluorescence level, may result from the antimicrobial activity of the antiseptic applied, but also, to some extent, from the rinsing procedures. Therefore, the mathematic formula enabling the assessment of the level of the impact of an antiseptic on staphylococcal biofilm should consist of two components, the first of which should deal with confluency changes, while the second one should deal with the changes in live cells number (measured indirectly with the SYTO-9 dye). Therefore, the first component was described as Biofilm-Covered Area (BCA), assessed as the percentage [%] of culture-well area covered by adherent cells. The exemplary image processing leading to BCA [%] calculation by means of ImageJ is presented in Figure 9. As an effect of this action, only areas above an established threshold value are considered to contain biofilm-forming cells, while the remaining areas are considered cell-free (the “holes,” non-fluorescent areas).
The BCA [%] calculated for the biofilm treated with antiseptic (Figure 8, right picture) was 49%, and 99% for the biofilm treated with saline, (Figure 8, left picture). Thus, the antiseptic activity correlated with a drop in BCA value by 50% (99–49%). The second parameter introduced to the formula was a drop in cell number in the BCA, referred to as the Biofilm Fluorescence Intensity Drop (BFID). It indicates the antiseptic-caused death of a certain number of cells (but not all of them) within a specific Z-axis (thickness) of the biofilm. To calculate the BFID, the FI of treated biofilm-covered areas was compared to the FI of non-treated biofilm areas. The BFID is calculated only for the Biofilm-Covered Area, not for black, non-fluorescent regions. Following the example of biofilms presented in Figure 8, the FI of BCA of treated biofilm and non-treated biofilm (BCA regions) was 44.99 vs. 104.38, respectively. It means that the FI in antiseptic-treated BCA constituted a fraction of 0.43, i.e., 44.98/104.38 of the non-treated biofilm. The BCA value of treated biofilm was 49%, thus, the fluorescence level in this area was decreased by 21.07% (0.43 × 49%). Therefore, the antiseptic activity against this not-completely-eradicated biofilm can be expressed as the BFID equal to 49% − 21.07% = 27.93%. Combining the BCA and BFID components, the following formula of Antiseptic’s Biofilm Eradication (ABE [%]) was achieved:
ABE   [ % ] = ( BCA non treated   biofilm     BCA treated   biofilm   ) + ( BCA treated   biofilm   FI treated   biofilm FI non treated   biofilm   ×   BCA treated   biofilm )
and after simplification:
ABE   [ % ] = BCA non treated   biofilm   FI treated   biofilm FI non treated   biofilm   ×   BCA treated   biofilm
Therefore, the ABE [%] for the exemplary staphylococcal biofilm treated with PVP-I (Figure 8) was 78.77%.
Having established the ABE [%] formula, the assessment of the effect of exemplary antiseptics (PHMB, PVP-I and NaOCl) on the staphylococcal biofilm of all 10 scrutinized strains was performed (Figure 10).
The results presented in Figure 10 show comparable antibiofilm activity of PHMB and PVP-I, and a statistically higher (p > 0.5) activity of these compounds in comparison to the NaOCl activity. Finally, the same experimental setting as the one presented in Figure 10 was performed, but the antiseptics’ antibiofilm activity was assessed using standard, quantitative culturing (QC) method. The [%] biofilm eradication was 48 ± 13%, 44 ± 5% and 10 ± 3% for PHMB, PVP-I and NaOCl, respectively. The results obtained by both methods (ABE% and QC) were cohesive, showing a comparable level of eradication after the use of PHMB and PVP-I, and a low level of eradication after the use of NaOCL. The differences in the eradication level recorded after use of ABE% and QC methods were 8.3%, 2.7% and 9% for PHMB, PVP-I and NaOCL, respectively.

3. Discussion

Biofilms can be perceived as highly differentiated biological systems, able to efficiently adapt to the specific conditions in the human organism [14]. Therefore, to assess the impact of antimicrobial agents on biofilm, differentiated techniques, measuring changes in biofilm’s crucial components, should be applied. In this regard, the culturing of biofilm-forming cells and metabolic activity assays provide data of respectively quantitative and semiquantitative character, while microscopic images of biofilms tagged with fluorescent dyes are presented frequently to back up the aforementioned results [15]. The aim of this line of investigation was to use the possibilities offered by the software for image processing and to provide quantitative data on the antibiofilm impact of antiseptic agents using microscopic images of biofilm dyed with reagents, differentiating live cells from the dead ones (“Live/Dead”). To obtain this aim, the features of staphylococcal biofilm, cultured in vitro, were firstly analyzed. The data presented in Figure 1, Figure 2, Figure 3, Figure 4 and Figure 5 can be summarized as follows: staphylococcal biofilm in vitro is a cellular structure of differentiated thickness and of highly confluent character. The rare gaps (“holes”) in the continuity of the biofilms are devoid of cells and/or they contain cellular debris. The bottom and the top parts of the biofilm display lower cellular density than the medium parts of the biofilm. The majority of dead cells in staphylococcal biofilm in vitro are localized in the bottom part of this structure; nevertheless, some of the biofilms also displayed a pattern in which dead cells prevailed not only in the bottom, but also in the top parts. Such staphylococcal biofilm heterogeneity may be of high importance with regard to the activity displayed by these antiseptics, which act through the disintegration of the microbial cell wall (for example polyhexamethylene biguanidine [6]). One may expect that their effectiveness may differ depending on the type of biofilm they will be used against, i.e., whether the antiseptic molecules will have an initial contact with the heavily damaged cells of such biofilm, as presented in Figure S1, pattern C, or with the mostly non-compromised cells forming biofilm structure presented in Figure S1, pattern A. In fact, the normative methods of assessment of antiseptic activity [16] imply the use of an “organic burden” (bovine serum albumin and/or blood cells) to analyze the impact of this load on antiseptic molecules activity, which is mostly negative (the effectiveness drops). One may hypothesize that the T part of the biofilm presented in Figure S1, pattern C may act in a similar manner as an organic load applied in normative methods. The antimicrobial activity of most antiseptics relies on the destruction of bacterial cell walls (and biofilm matrix) and one may hypothesize that the result of such activity may be empty spaces in the biofilm structure, contributing to the drop in confluency level. Such a drop in confluency is commonly observed in eukaryotic cell cultures in vitro after the introduction of molecules displaying high cytotoxic potential [17]. The occurrence of holes (black, non-fluorescent areas) in biofilm, would also suggest that the specific antiseptic was able to penetrate through the whole biofilm structure (from part T to B along the Z-axis and to kill biofilm-forming cells). The high tolerance of the deeper parts of biofilms to antibiotics and the immune system components is one of the main clinically recognized challenges impeding effective biofilm eradication [18]. Therefore, these antiseptics, whose activity correlates with the formation of new holes within biofilms, should be considered the most effective. The analysis of the properties of staphylococcal biofilm in vitro should also include another factor, namely the height (thickness) of the biofilm, understood as the number of subsequent cells along the Z-axis. The parameter of thickness is crucial in regard to the application of antiseptics against biofilm because it may be hypothesized that the application of cell wall-destructing antiseptics should lead to the removal of cells and to a decrease in biofilm thickness. This assumption is valid not only because of the aforementioned activity mechanism of these antiseptics, but also because of the rheological phenomena occurring during antiseptics’ introduction, removal and subsequent laboratory stages of dye introduction and microplate well rinsing. As was observed, the measured thickness of staphylococcal biofilms differed not only between particular strains, explicitly showing the importance of intra-species variability [19], but also within a single sample (well of a 24-well microplate). This thickness differentiation is meaningful, taking into consideration the activity of antiseptics against biofilm. Firstly, the process of pouring in antiseptics initiates a number of rheological and dynamic processes, resulting in (random from our perspective) the breaking off of biofilm parts. Secondly, the level of biofilm eradication depends on the specific antiseptic agent’s mode of action, its ability to penetrate through the matrix and on the cells’ susceptibility. It may be hypothesized that the thinner the biofilm in a particular area, the higher the probability that the activity of an antiseptic will result in higher biofilm removal and formation of holes. Nevertheless, as shown in Table 1, the thickness of biofilm does not always correspond to the cellular density of cells measured by fluorescence level. The attempt to explain this phenomenon is presented in Figure 11.
Following this thought, these thinner parts of biofilm, which display high cellular density, may be harder to eradicate than biofilm that is thicker but consists of a lower number of cells. The above-mentioned considerations are valid if we assume that the level of emitted fluorescence is the same (or at least approximately the same) for every cell in the biofilm, regardless of its physiological state and spatial location within the biofilm. Unfortunately, the performance of an experiment aiming to check the aforementioned possible differences is far beyond the technological possibilities offered by contemporary technology. After analysis of crucial features of the staphylococcal biofilm, in the next step of investigation, the determination of the impact of liquid introduction/removal to the experimental setting was performed. With regard to the images and quantitative data obtained by means of confocal/epifluorescent microscopy, the de-attachment of biofilm during procedure of rinsing is of paramount (and negative) importance, because it leads to the formation of random holes in the biofilm structure, which may be interpreted as resulting from the eradicative force of the introduced antiseptics. The standard procedure of analysis of antiseptic impact on biofilm in vitro includes at least 11 steps of liquid introduction and removal. These are: (i) aspiration of medium, (ii) introduction/removal of rinsing liquid, (iii) introduction/removal of antiseptic agent, (iv) introduction/removal of antiseptic neutralizer, (v) introduction/removal of L/D mixture, (vi) introduction/removal of rinsing liquid). The number of steps may be higher, because specific protocols recommend the repetition of specific steps (mostly ii and vi) two or three times. Based on the data shown in Figure S3, it can be stated that the alterations of biofilm structure when all these steps are applied (bearing also in mind the fact that one of them, antiseptic agent introduction, leads to the destruction of cells) are of a massive and rather unpredictable, character. In our opinion, this is one of the most important variables during the whole process of the assessment of antiseptic agent impact on staphylococcal biofilm in vitro. The fact that some research teams recommend rinsing the plates with tap water or shaking the plate out over a waste tray [20] additionally and rather strongly impedes the obtainment of repeatable and conclusive results. Nevertheless, the processes of liquid introduction and removal cannot be omitted if L/D dyeing is to be performed. The solutions aiming to decrease, to some extent, the negative impact of rinsing on the reproducibility of results involve: (i) gentle aspiration and removal of liquid during manual pipetting, (ii) placing the tip of the pipette in the same position (preferably on the rim of the plate’s well), (iii) if possible, reducing the amount of rinsing and, last but not least, the performance of an appropriate number of technical repeats and independent experiments (performed in accordance with the general methodology of biological quantitative experiments). The process of rinsing is of paramount importance not only due to the impact on the staphylococcal biofilm structure and confluency, but also because it correlates with an uneven change in the fluorescence intensity level measured for SYTO-9 (“live”) and PI (“dead”) cells. This statement is one of the main discoveries made in the present study because it redefines the usability of the last-mentioned dye for the analyses of the impact of antiseptic agents on staphylococcal biofilm. As can be seen in Figure 7, the subsequent rinsing steps lead to a significantly stronger reduction of the PI fluorescence level compared to the reduction in the SYTO-9 fluorescence level. This observed fluorescence intensity drop could also be due to the phenomenon referred to as photobleaching, as well as due to the lower photostability of PI compared to SYTO-9 [21]. It may also be hypothesized that PI binds to damaged/compromised cells (examples of such cells are presented in the right panel of Figure 7), which are more vulnerable to be flushed out by the introduced liquid. The general concept of application of these two dyes is based on the idea that the activity of an antimicrobial should correlate with a drop in fluorescence level from SYTO-9-dyed cells, with a simultaneous increase in the fluorescence level from PI-dyed cells. However, the observation from this study (Figure 7) explicitly shows that PI is of lower usability for quantitative analyses of staphylococcal biofilm in vitro than the SYTO-9 dye. In our opinion, the application of PI may be valid for images of a high aesthetic value, while the quantitative measurement of the viability of staphylococcal, biofilm-forming cells should be performed with the use of SYTO-9 only (by comparison of the levels of SYTO-9 fluorescence between biofilm treated with antimicrobial and untreated, control biofilm). The above statement is particularly valid with regard to these antiseptic agents, which disintegrate the continuity of staphylococcal cell walls. In turn, the verification of the discovery presented in Figure 7 with regard to bacteriostatic agents undoubtedly requires an experimental confirmation. It is worth noting that the proposal of the application of only SYTO-9 for measuring the drop in biofilm’s viability resembles the methodology applied in normative analyses of eukaryotic cell lines (cytotoxicity tests, for example), where the drop in live cells (dyed with tetrazolium salts) is measured after biocide introduction and compared to the untreated control [22]. Moreover, within biofilm structure, a certain population of cells is considered to be “viable, but non-culturable” (VNBC; such cells display a higher resistance to antimicrobials than viable, culturable cells). Because SYTO-9 binds to the VNBC cells, the measured level of fluorescence in the untreated control may include also fluorescence from these cells. On the other hand, such cells are still considered “infective” (and able to cause for example, aseptic loosening of an implant [23]), so their detection as part of infective biofilm should be considered valid. A schematic explanation of the phenomena occurring during the introduction of antiseptics, summarizing data collected in this research and resulting in specific types of images from confocal or epifluorescent microscope, is presented in the upper and lower panels of Figure 12, respectively.
Based on the data obtained in the course of this investigation, the mathematic formula, referred to as the ABE [%], was elucidated. Figure 10 shows its implementation to assess the antibiofilm activity of three commonly applied antiseptic agents—PHMB, PVP-I and NaOCl. By means of ABE [%], the comparable antibiofilm activity of PHMB and PVP-I, and a statistically higher (p > 0.5) activity of these compounds, in comparison to the NaOCl activity, was shown. Such results confirm the methodological usability of ABE [%], as they stay in line with the data previously presented by our and other teams concerning the activity of these three wound antiseptics [24,25,26]; including the lack of effectiveness of NaOCl, containing low, 80 ppm hypochlorite content, which was already shown by Severing et al. [13]. Thus, by research performed in this study, not only was a new tool to assess the antiseptic activity against staphylococcal biofilm (ABE [%]) developed, but also, on a general level, another dataset confirming the usability of microscopic analysis combined with image processing in studies on antiseptics was provided. Although our research may be considered an important step towards complex analyses of antiseptics’ activity against staphylococcal biofilms, we are also aware of certain disadvantages of our work. Firstly, to keep the number of variables under control, basically only 24 h-old biofilms were analyzed. If “younger” and “older” biofilms were included in the investigation line, other patterns of cellular density, biofilm thickness and L/D-dyed cell spatial composition would probably be detected. Secondly, just one type of culturing medium (Tryptic Soy Broth) was applied, while high differences in biofilm structures formed by the same strain, but cultured in different media, were already observed [27]. Thirdly, only a polystyrene surface was used to culture biofilms, though the impact of various surface types on biofilm structure is undisputable and proven [28]. As mentioned, our aim was to keep the number of variables under control; therefore, analyses were performed in one particular setting (24 h biofilm, TSB medium, polystyrene surface). The implementation of additional variables would translate into an overload of data. Therefore, in future investigations, the validation of the applicability of the ABE [%] formula needs to be performed using not only various broths, pathogens and surfaces, but also a higher number of antiseptics of different mechanisms of action and areas of use. Still, we are convinced that the range of already-performed analyses indicates the directions of subsequent paths that may be explored by other research teams with an aim to increase our knowledge of the phenomena occurring when staphylococcal biofilm is exposed to an activity of locally acting antiseptic agents. Taking into account the fact that in vitro results of the efficacy of antiseptic agents against staphylococcal biofilm are frequently applied to back up their use in hospitals and ambulatory units, our work should be considered an important tool; providing reliable, quantitative data in this regard.

4. Materials and Methods

4.1. Antiseptics Applied

(a)
Prontosan wound irrigation solution® (B. Braun, Melsungen, Hessen, Germany), composed of purified water, 0.1% betaine surfactant, and 0.1% polyaminopropyl biguanide (polyhexanide), later referred to as PHMB;
(b)
Granudacyn® Wound Irrigation Solution (Molnlycke Health Care AB, Göteborg, Sweden), composed of water, sodium chloride, 0.005% sodium hypochlorite, and 0.005% hypochlorous acid, later referred to as NaOCl;
(c)
Braunol® (B. Braun, Melsungen, Hessen, Germany), composed 7.5% povidone–iodine with 10% available iodine, sodium dihydrogen phosphate dihydrate, sodium iodate, macrogol lauryl ether, sodium hydroxide, and purified water, later referred to as PVP-I.

4.2. Staphylococcal Strains and Biofilm Culturing In Vitro

Two reference strains from the American Type Culture Collection (ATCC), Staphylococcus aureus 6538 and 33591, and 8 clinical strains isolated from chronic wound infections, were chosen. All staphylococcal strains are part of the collection of the Department of Pharmaceutical Microbiology and Parasitology of Wroclaw Medical University, collected during a research project approved by the Bioethical Committee of Wroclaw Medical University, protocol # 8/2016. The strains were transferred from Columbia Agar (Biomaxima, Lublin, Poland) to liquid Tryptic Soya Broth (Biomaxima, Lublin, Poland) and incubated for 24 h/37 °C. Next, they were diluted using densitometer (Densilameter II, Erba Lachema, Brno, the Czech Republic) to 0.5 McFarland and with serial dilution to ca. 105 cfu/mL. The number of cfu was additionally checked by quantitative culturing on Columbia Agar. 2 mL of staphylococcal suspensions of 105 cfu/mL were transferred to the wells of the 24-well plates (Wuxi Nest Biotechnology, Wuxi, China) and incubated for 24 h/37 °C. Afterwards, the medium containing planktonic cells was gently removed, and the well was rinsed once with saline (Stanlab, Lublin, Poland). Such prepared biofilms were subjected to subsequent analyses. The above methodology was applied in all cases, except:
-
The setting presented in Figure 1A, where the biofilm was cultured for 12 h.
-
The setting presented in Figure 2 where the biofilm was cultured for 24 h inside of microscopic glass (Medical Depot, Warsaw, Poland).
-
The setting presented in Figure 6, where the medium was removed from 24 h-old biofilm and the images were taken using bright light vision in an Etaluma Lumascope 620 fluorescent microscope (San Diego, CA, USA).

4.3. Live/Dead Dyeing of Staphylococcal Biofilms and Microscopic Visualization

Staphylococcal biofilms, cultured as presented in Section 4.2 were labeled with 500 µL of Live/Dead solution (Filmtracer™ Live/dead™ Biofilm Viability Kit, Thermo Fisher Scientific, Waltham, MA, USA) according to the protocol provided by the manufacturer. After 20 min of incubation without light, the staining solution was gently removed and samples were rinsed once with filter-sterilized water. Such prepared samples were subjected to subsequent analyses. The microscopic visualizations were performed using a wide-field LS620 fluorescent microscope (Etaluma, San Diego, CA, USA) and two confocal microscopes: a Cell Observer SD spinning disk system (Zeiss, Oberkochen, Germany) and an SP8 MP laser-scanning confocal microscope (Leica, Wetzlar, Germany). SYTO-9 showing live bacteria was excited at 488 nm wavelength using a LED (LS620) or a laser line (Cell Observer and SP8). The collected emission was within the 502–561 nm (LS620), 502–538 nm (Cell Observer) or 500–530 nm (SP8) ranges. Propidium iodide (PI) for the visualization of dead bacteria was excited with a 594 nm LED (LS620), 561 nm laser line (Cell Observer) or 552 nm laser line (SP8). The emission of PI was collected within the 612–680 nm (LS620), 575–625 nm (Cell Observer and SP8) ranges. The acquisition was performed using 20× dry objectives in a sequence to avoid a spectral bleed through. For a given set of experimental conditions (untreated biofilm and biofilms with antiseptics), the same acquisition settings were applied on each system (LED/laser power, exposure time (LS620 and Cell Observer), camera/photomultiplier gain) to enable quantitative comparisons between the conditions. The settings and signal intensity were always set on the brightest samples to avoid oversaturation. Fluorescence intensities were measured in single wide-field images from a focus plane (LS620) or in single optical planes recorded on confocal systems in the Fiji/ImageJ software (NIH, Bethesda, MD, USA). Data are presented as single planes or maximum intensity projections of confocal Z stacks, rendered in the Imaris software (Oxford Instruments, Abingdon, UK). PI is shown in red/orange and SYTO-9 in green color. The denotations “top,” “middle” and “bottom” used to describe the thickness of the biofilm structure are applied according to their biological meaning, i.e., (“bottom”—the part of the biofilm in direct contact with the plate surface, “middle”—the part of the biofilm placed over the surface-adhered layer; “top”—the part of the biofilm constituting the apexes of the hill-like biofilm structure).

4.4. Scanning Electron Microscopy Analysis

The biofilms were cultured in the analogical manner as described in Section 4.2, with such a difference that the polystyrene coupons were placed in the bottom of the 24-well plate and served as the surface for staphylococcal biofilm growth. Next, the samples were gently cleansed in PBS (Sigma-Aldrich, Darmstad, Germany) buffer; fixed in glutaraldehyde [28] (POCH, Wroclaw, Poland) and dried in a critical point dryer EM CPD300 (Leica Microsystems, Wetzlar, Germany). Subsequently, the samples were subjected to sputtering with Au/Pd (60:40) using EM ACE600, Leica sputter (Leica Microsystems, Wetzlar, Germany). The sputtered samples were examined using a scanning electron microscope (SEM, Auriga 60, Zeiss, Germany).

4.5. Staining Staphylococcal Biofilms with Crystal Violet Method

The 0.5 McFarland density of the bacteria suspension in TSB medium was prepared, then diluted to 1 × 105 CFU/mL. A total of 1 mL of the suspension was added to the well of a 24-well microtiter plate (Wuxi Nest Biotechnology, Wuxi, China) and incubated for 24 h at 37 °C. Subsequently, the non-adhered cells were removed, and the plate was dried for 10 min at 37 °C. Next, 1 mL of 20% (v/v) water solution of crystal violet (Aqua-med, Lodz, Poland) was added, and the mixture was incubated for 10 min at room temperature. After incubation, the solution was removed, the biofilm was gently washed twice with 100 μL of 0.9% NaCl (Stanlab, Lublin, Poland) and dried for the next 10 min. Next, the image of the dyed biofilm was captured photographically.

4.6. Impact of Rinsing on Fluorescence Intensity of SYTO-9 and Propidium Iodine

The procedures were performed as in Section 4.2 and Section 4.3 with such a difference that rinsing with water was performed one, two, three or four times. After every rinsing, analysis with use of Etaluma Lumascope 620 fluorescent microscope (San Diego, CA, USA), as performed in Section 4.3, was performed to capture the changes in Fluorescence Intensity from SYTO-9 and propidium iodine dyes.

4.7. Image Processing of Staphylococcal Biofilms Using ImageJ Software

The captured biofilm pictures were processed using ImageJ version 8 (National Institutes of Health, Bethesda, MD, USA) First, RGB pictures were divided into green and red channel sub-images and subsequently changed into 32-bite grey types. Next, the mean grey value was extracted from images of every type. The mean grey value correlates with the value of fluorescence intensity and it is defined as the sum of the values at all pixels divided by the number of pixels. For clarity sake, the OY axes in the Figures dealing with intensity values are presented as Fluorescence Intensity. In these cases, when the application of the ABE [%] formula required the assessment of BCA [%] (Biofilm-Covered Area), the images were changed into 32-bite grey type. Next, the threshold option was applied to differentiate the regions of interest (staphylococcal biofilm) from the areas non-covered with biofilm (referred to as the “Background”); subsequently, the options Analyze->Set Measurements->Area were applied to calculate the percentage of area covered with biofilm.

4.8. The Assessment of Antiseptic Biofilm Eradication Value

The staphylococcal biofilms were cultured as described in Section 4.2; each strain with 6 technical repeats. After medium removal, 1 mL of antiseptic (PHMB, NaOCL or PVP-I) or saline (control) was introduced for 1 h. Next, antiseptics or saline were removed and the universal neutralizing agent (Saline Peptone Water, Biocorp, Warsaw, Poland) was introduced for 5 min. Afterwards, the neutralizing agent was removed. Then, Live/Dead dye was introduced, as presented in Section 4.3. Twelve fields of view (FoV) for each replicate (in every biofilm-covered well) were imaged. The selection excluded FoVs from the peripheral parts of the well, because of the strong removal of dyed biofilm cells due to shear forces, which resulted in very high standard deviations of obtained fluorescence data. Therefore, the FoVs were taken from the center of the well in the following manner: the oval mark was made (using felt tip pen) on the center of the well’s external surface (the most external, bottom part of plate, the one touching incubator) before biofilm culturing and further processing. After sample staining, 4 × 3 fields of vision were taken (3 fields above the oval mark, 3 fields below the oval mark, 3 fields from the left and 3 fields from the right side of the mark). It provided (4 × 3) × 6 FoVs. The images were taken with Etaluma Lumascope 620 fluorescent microscope. The estimation of Fluorescence Intensity (measured by Mean Grey Value) and Biofilm-Covered Areas were performed as presented in Section 4.7. To compare the results of ABE [%] with standard method of antibiofilm activity assessment, quantitative culturing was performed. The biofilm culturing, antiseptic introduction and neutralization were performed in the exact the same manner as in the case of the experiment described for ABE [%] assessment. After neutralization, 1 mL of 0.5% saponin (Sigma Aldrich) was introduced to the wells of the 24-well plate, and the entire setting was subjected to mechanical shaking for 1 min to de-attach the biofilm. Subsequently, the serial dilutions of the obtained staphylococcal suspension in saline were performed; 100 µL of every dilution was cultured on the Columbia Agar plates. The plates were incubated at 37 °C for 24 h, and the number of staphylococcal colonies were counted afterwards.

4.9. Statistical Analysis

Calculations were performed using the GraphPad Prism version 7 software (GraphPad Co., San Diego, CA, USA). The normality of distribution was assessed by means of the D’Agostino–Pearson omnibus test. Because all values were non-normally distributed, the Kruskal–Wallis test with post-hoc Dunnett analysis were applied. The results of the statistical analyses were considered significant if they produced p-values < 0.05

5. Conclusions

The staphylococcal biofilm in vitro displays a confluent structure of differentiated thickness and ratio of live to dead cells. These differences depend on intraspecies features.
The preparation procedures (rinsing, especially) for microscopic analysis and further image processing significantly alter biofilm structure and have an impact on analyses related to the application of antiseptic agents.
The SYTO-9 dye represents a higher value for the quantitative assessment of the antiseptic impact on biofilm than does propidium iodide (PI).
The formula of Antiseptic’s Biofilm Eradication developed and scrutinized in this research may be highly applicable in the assessment of antiseptic activity against 3-dimensional biofilm structures.

Supplementary Materials

The supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/ijms232113524/s1.

Author Contributions

Conceptualization: G.K., K.F. and A.J.; methodology, G.K. and A.J.; software, A.J.; validation, A.J.; formal analysis, G.K. and A.J.; investigation, G.K., A.J., M.W., P.M., J.C., B.D., J.N., J.P., M.B., M.O.-W., G.C. and B.K.; resources, G.K., A.J. and K.F.; data curation, G.K.; writing—original draft preparation, G.K. and A.J.; writing—review and editing, A.J.; visualization, A.J.; supervision, A.J.; project administration, A.J.; funding acquisition, K.F. and A.J. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by National Science Center (Grant No. 2017/27/B/NZ6/02103).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data-set and raw images applied to perform the image panels presented in this study are available in public repository FigShare under the address provided: https://figshare.com/articles/dataset/Data_and_Image_Set/20391495 (accessed on 20 October 2022) under the license CCBY 4.0.

Acknowledgments

AJ would like to thank Howard Bloom (N.Y.C.) who taught him to always ask: “What do I actually see here?”

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Le, K.Y.; Dastgheyb, S.; Ho, T.V.; Otto, M. Molecular Determinants of Staphylococcal Biofilm Dispersal and Structuring. Front. Cell. Infect. Microbiol. 2014, 4, 1–7. [Google Scholar] [CrossRef] [PubMed]
  2. Rodrigues, C.F.; Kaushik, K.S.; Light, C. Biofilms in Wounds: New Advances in Therapy and in Healing Management. Biomedicines 2021, 9, 193. [Google Scholar] [CrossRef]
  3. Roy, S.; Santra, S.; Das, A.; Dixith, S.; Sinha, M.; Ghatak, S.; Ghosh, N.; Banerjee, P.; Khanna, S.; Mathew-Steiner, S.; et al. Staphylococcus aureus Biofilm Infection Compromises Wound Healing by Causing Deficiencies in Granulation Tissue Collagen. Ann. Surg. 2020, 271, 1174–1185. [Google Scholar] [CrossRef] [PubMed]
  4. Malone, M.; Bjarnsholt, T.; McBain, A.J.; James, G.A.; Stoodley, P.; Leaper, D.; Tachi, M.; Schultz, G.; Swanson, T.; Wolcott, R.D. The Prevalence of Biofilms in Chronic Wounds: A Systematic Review and Meta-Analysis of Published Data. J. Wound Care 2017, 26, 20–25. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Kramer, A.; Dissemond, J.; Kim, S.; Willy, C.; Mayer, D.; Papke, R.; Tuchmann, F.; Assadian, O. Consensus on Wound Antisepsis: Update 2018. Skin Pharmacol. Physiol. 2018, 31, 28–58. [Google Scholar] [CrossRef]
  6. Hübner, N.O.; Kramer, A. Review on the Efficacy, Safety and Clinical Applications of Polihexanide, a Modern Wound Antiseptic. Skin Pharmacol. Physiol. 2010, 23, 17–27. [Google Scholar] [CrossRef]
  7. Tawakoli, P.N.; Al-Ahmad, A.; Hoth-Hannig, W.; Hannig, M.; Hannig, C. Comparison of different live/dead stainings for detection and quantification of adherent microorganisms in the initial oral biofilm. Clin. Oral Investig. 2013, 17, 841–850. [Google Scholar] [CrossRef]
  8. Netuschil, L.; Auschill, T.M.; Sculean, A.; Arweiler, N.B. Confusion over live/dead stainings for the detection of vital microorganisms in oral biofilms—which stain is suitable? BMC Oral Health 2014, 14, 2. [Google Scholar] [CrossRef] [Green Version]
  9. Legner, M.; Jonkman, J.; Swift, D. Evaluating the Effects of Disinfectants on Bacterial Biofilms Using a Microfluidics Flow Cell and Time-Lapse Fluorescence Microscopy. Microorganisms 2020, 8, 1837. [Google Scholar] [CrossRef]
  10. Schneider, C.A.; Rasband, W.S.; Eliceiri, K.W. NIH Image to ImageJ: 25 Years of Image Analysis. Nat. Methods 2012, 9, 671–675. [Google Scholar] [CrossRef]
  11. Hartmann, R.; Jeckel, H.; Jelli, E.; Singh, P.K.; Vaidya, S.; Bayer, M.; Rode, D.K.H.; Vidakovic, L.; Díaz-Pascual, F.; Fong, J.C.N.; et al. Quantitative image analysis of microbial communities with BiofilmQ. Nat Microbiol. 2021, 6, 151–156. [Google Scholar] [CrossRef] [PubMed]
  12. Kramer, A.; Assadian, O.; Muller, G.; Reichwagen, S.; Widulla, H.; Heldt, P.; Nurnberg, W. Octenidine, Chlorhexidine, Iodine and Iodophores; Thieme, G., Ed.; Stuttgart: New York, NY, USA; Berlin, Germany, 2008. [Google Scholar]
  13. Severing, A.L.; Rembe, J.D.; Koester, V.; Stuermer, E.K. Safety and Efficacy Profiles of Different Commercial Sodium Hypochlorite/Hypochlorous Acid Solutions (NaClO/HClO): Antimicrobial Efficacy, Cytotoxic Impact and Physicochemical Parameters in Vitro. J. Antimicrob. Chemother. 2019, 74, 365–372. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Kassinger, S.J.; van Hoek, M.L. Biofilm architecture: An emerging synthetic biology target. Synth. Syst. Biotechnol. 2020, 5, 1–10. [Google Scholar] [CrossRef] [PubMed]
  15. Ciecholewska-Juśko, D.; Żywicka, A.; Junka, A.; Woroszyło, M.; Wardach, M.; Chodaczek, G.; Szymczyk-Ziółkowska, P.; Migdał, P.; Fijałkowski, K. The effects of rotating magnetic field and antiseptic on in vitro pathogenic biofilm and its milieu. Sci. Rep. 2022, 12, 8836. [Google Scholar] [CrossRef]
  16. EN 13727: Chemical Disinfectants and Antiseptics—Quantitative Suspension Test for the Evaluation of Bactericidal Activity in the Medical Area. Available online: https://www.situbiosciences.com/product/en-13727-chemical-disinfectants-and-antiseptics-quantitative-suspension-test-for-the-evaluation-of-bactericidal-activity-in-the-medical-area/ (accessed on 4 November 2021).
  17. Geraghty, R.J.; Capes-Davis, A.; Davis, J.M.; Downward, J.; Freshney, R.I.; Knezevic, I.; Lovell-Badge, R.; Masters JR, W.; Meredith, J.; Stacey, G.N.; et al. Guidelines for the Use of Cell Lines in Biomedical Research. Br. J. Cancer 2014, 111, 1021–1046. [Google Scholar] [CrossRef] [Green Version]
  18. Mah TF, C.; O’Toole, G.A. Mechanisms of Biofilm Resistance to Antimicrobial Agents. Trends Microbiol. 2001, 9, 34–39. [Google Scholar] [CrossRef]
  19. Woroszyło, M.; Ciecholewska-Juśko, D.; Junka, A.; Pruss, A.; Kwiatkowski, P.; Wardach, M.; Fijałkowski, K. The Impact of Intraspecies Variability on Growth Rate and Cellular Metabolic Activity of Bacteria Exposed to Rotating Magnetic Field. Pathogens 2021, 10, 1427. [Google Scholar] [CrossRef]
  20. Merritt, J.H.; Kadouri, D.E.; O’Toole, G.A. Growing and analyzing static biofilms. Curr. Protoc. Microbiol. 2005, 1, 2–29. [Google Scholar] [CrossRef] [Green Version]
  21. Schlafer, S.; Meyer, R.L. Confocal microscopy imaging of the biofilm matrix. J. Microbiol. Methods 2017, 138, 50–59. [Google Scholar] [CrossRef]
  22. ISO 10993-5:2009(en); Biological Evaluation of Medical Devices—Part 5: Tests for In Vitro Cytotoxicity. ISO: Geneva, Switzerland, 2021. Available online: https://www.iso.org/obp/ui/#iso:std:iso:10993:-5:ed-3:v1:en (accessed on 4 November 2021).
  23. Pasquaroli, S.; Zandri, G.; Vignaroli, C.; Vuotto, C.; Donelli, G.; Biavasco, F. Antibiotic Pressure Can Induce the Viable but Non-Culturable State in Staphylococcus Aureus Growing in Biofilms. J. Antimicrob. Chemother. 2013, 68, 1812–1817. [Google Scholar] [CrossRef]
  24. Krasowski, G.; Junka, A.; Paleczny, J.; Czajkowska, J.; Makomaska-Szaroszyk, E.; Chodaczek, G.; Majkowski, M.; Migdał, P.; Fijałkowski, K.; Kowalska-Krochmal, B.; et al. In Vitro Evaluation of Polihexanide, Octenidine and NaClO/HClO-Based Antiseptics against Biofilm Formed by Wound Pathogens. Membranes 2021, 11, 62. [Google Scholar] [CrossRef] [PubMed]
  25. Gottrup, F.; Apelqvist, J.; Bjansholt, T.; Cooper, R.; Moore, Z.; Peters EJ, G.; Probst, S. EWMA Document: Antimicrobials and Non-Healing Wounds Evidence, Controversies and Suggestions. J. Wound Care 2013, 22, S1–S89. [Google Scholar] [CrossRef] [PubMed]
  26. Müller, G.; Kramer, A. Biocompatibility Index of Antiseptic Agents by Parallel Assessment of Antimicrobial Activity and Cellular Cytotoxicity. J. Antimicrob. Chemother. 2008, 61, 1281–1287. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  27. Paleczny, J.; Junka, A.; Brożyna, M.; Dydak, K.; Oleksy-Wawrzyniak, M.; Ciecholewska-Juśko, D.; Dziedzic, E.; Bartoszewicz, M. The High Impact of Staphylococcus Aureus Biofilm Culture Medium on In Vitro Outcomes of Antimicrobial Activity of Wound Antiseptics and Antibiotic. Pathogens 2021, 10, 1385. [Google Scholar] [CrossRef] [PubMed]
  28. Bogino, P.C.; Oliva, M.D.l.M.; Sorroche, F.G.; Giordano, W. The Role of Bacterial Biofilms and Surface Components in Plant-Bacterial Associations. Int. J. Mol. Sci. 2013, 14, 15838–15859. [Google Scholar] [CrossRef]
Figure 1. (A)—Young, 12 h staphylococcal ATCC 6538 biofilm grown in a microplate (24-well) seen in an optical microscope (aerial perspective) without any prior preparative procedures; red arrows indicate areas of higher cellular density (mushroom-like structures); (B)—aerial perspective of L/D-dyed, 24 h biofilm of the same strain. The “1s” show areas non-covered with cells (holes); the 2s” show areas of lower cellular density (of lower intensity of green color) than areas designated with “3s” (of higher density of green color). Red shapes are cells of decreased viability (with a compromised cell wall) or dead; while green shapes are viable cells (of non-compromised cell wall). Picture (A), inverted microscope DMIL LED, magnification 10×; Picture (B), confocal microscope SP8, magnification 40×.
Figure 1. (A)—Young, 12 h staphylococcal ATCC 6538 biofilm grown in a microplate (24-well) seen in an optical microscope (aerial perspective) without any prior preparative procedures; red arrows indicate areas of higher cellular density (mushroom-like structures); (B)—aerial perspective of L/D-dyed, 24 h biofilm of the same strain. The “1s” show areas non-covered with cells (holes); the 2s” show areas of lower cellular density (of lower intensity of green color) than areas designated with “3s” (of higher density of green color). Red shapes are cells of decreased viability (with a compromised cell wall) or dead; while green shapes are viable cells (of non-compromised cell wall). Picture (A), inverted microscope DMIL LED, magnification 10×; Picture (B), confocal microscope SP8, magnification 40×.
Ijms 23 13524 g001
Figure 2. The Z axis image stack visualizing ATCC 6538 staphylococcal biofilm from the side aerial perspective (A). Part (B) of the figure shows the vertical cross-section through the three-dimensional biofilm structure, where the regions of various height and density are explicitly visible. Microscope Cell Observer, magnification 40×.
Figure 2. The Z axis image stack visualizing ATCC 6538 staphylococcal biofilm from the side aerial perspective (A). Part (B) of the figure shows the vertical cross-section through the three-dimensional biofilm structure, where the regions of various height and density are explicitly visible. Microscope Cell Observer, magnification 40×.
Ijms 23 13524 g002
Figure 3. Typical distribution of cellular density through the biofilm (ATCC 6538 strain) from its top to the bottom section (A,B) and the growing share of dead/cell wall compromised cells in the deeper parts of biofilm (A,C). Thickness of every section was 2.16µm. Red and green color in (A) represents Fluorescence Intensity of propidium iodide or SYTO-9, respectively; microscope SP8, magnification 40×. Scale bar is 50 µm.
Figure 3. Typical distribution of cellular density through the biofilm (ATCC 6538 strain) from its top to the bottom section (A,B) and the growing share of dead/cell wall compromised cells in the deeper parts of biofilm (A,C). Thickness of every section was 2.16µm. Red and green color in (A) represents Fluorescence Intensity of propidium iodide or SYTO-9, respectively; microscope SP8, magnification 40×. Scale bar is 50 µm.
Ijms 23 13524 g003
Figure 4. The presence of black non-fluorescent areas (“holes”) in the biofilm of the S1 strain. The upper part of the figure shows holes in the area magnified 20× (the upper panel consists of a composite image (L/D) and split channels (“live”—middle picture; “dead”—right picture). The bar size is 20 µm. The “holes” are non-fluorescent (black areas) in any channel in this magnification. In turn in the 100× magnification (lower panel), “holes” take forms of non-fluorescent or red-fluorescent areas. Bar size is 1µm. For higher visibility, in the lower panel, the dye distribution (color fluorescence) was presented in the grey (from white to black) spectrum of colors. Upper panel: microscope LumaScope 600, magnification 20× (the bars show size of 10 µm); Lower panel: Microscope Cell Observer, magnification 100×.
Figure 4. The presence of black non-fluorescent areas (“holes”) in the biofilm of the S1 strain. The upper part of the figure shows holes in the area magnified 20× (the upper panel consists of a composite image (L/D) and split channels (“live”—middle picture; “dead”—right picture). The bar size is 20 µm. The “holes” are non-fluorescent (black areas) in any channel in this magnification. In turn in the 100× magnification (lower panel), “holes” take forms of non-fluorescent or red-fluorescent areas. Bar size is 1µm. For higher visibility, in the lower panel, the dye distribution (color fluorescence) was presented in the grey (from white to black) spectrum of colors. Upper panel: microscope LumaScope 600, magnification 20× (the bars show size of 10 µm); Lower panel: Microscope Cell Observer, magnification 100×.
Ijms 23 13524 g004
Figure 5. Measured thickness of staphylococcal biofilms (n = 10) in vitro.
Figure 5. Measured thickness of staphylococcal biofilms (n = 10) in vitro.
Ijms 23 13524 g005
Figure 6. The impact of medium removal on the distribution of staphylococcal (ATCC33591) biofilm within 90 s of observation. Numbers 1–4 designate exemplary staphylococcal cell aggregates drifting over time and re-shaping biofilm structure. The lower panel presents changes in staphylococcal biofilm distribution following the implementation of image processing software. The scale bar is 10 µm, magnification 40×, microscope Lumascope 600. Please click the https://www.youtube.com/watch?v=uwTtHIurDfw&t=24s (accessed on 20 October 2022) to watch a video showing the process of biofilm de-attachment.
Figure 6. The impact of medium removal on the distribution of staphylococcal (ATCC33591) biofilm within 90 s of observation. Numbers 1–4 designate exemplary staphylococcal cell aggregates drifting over time and re-shaping biofilm structure. The lower panel presents changes in staphylococcal biofilm distribution following the implementation of image processing software. The scale bar is 10 µm, magnification 40×, microscope Lumascope 600. Please click the https://www.youtube.com/watch?v=uwTtHIurDfw&t=24s (accessed on 20 October 2022) to watch a video showing the process of biofilm de-attachment.
Ijms 23 13524 g006
Figure 7. The impact of subsequent rinsing steps on fluorescence intensity of SYTO-9 (L) and PI-dyed (D) biofilm-forming cells of the ATCC6538 strain. The right panel shows staphylococcal cells of an intact cellular wall (green frame) and staphylococcal cells of an increasing level of cell wall damage (red frames) in result of rinsing. The scale bar is 200 nm. Magnification 100,000×, Microscope Auriga 60.
Figure 7. The impact of subsequent rinsing steps on fluorescence intensity of SYTO-9 (L) and PI-dyed (D) biofilm-forming cells of the ATCC6538 strain. The right panel shows staphylococcal cells of an intact cellular wall (green frame) and staphylococcal cells of an increasing level of cell wall damage (red frames) in result of rinsing. The scale bar is 200 nm. Magnification 100,000×, Microscope Auriga 60.
Ijms 23 13524 g007
Figure 8. Staphylococcal biofilm of the ATCC 6538 strain non-treated (left picture) and treated (right picture) with an antiseptic (PVP-iodine). Biofilms dyed with SYTO-9 only. Aerial perspective, epifluorescent microscopy. Data collected with wide-field Lumascope 620 magnification 20×, scale bar is 10 µm.
Figure 8. Staphylococcal biofilm of the ATCC 6538 strain non-treated (left picture) and treated (right picture) with an antiseptic (PVP-iodine). Biofilms dyed with SYTO-9 only. Aerial perspective, epifluorescent microscopy. Data collected with wide-field Lumascope 620 magnification 20×, scale bar is 10 µm.
Ijms 23 13524 g008
Figure 9. Processing of biofilm image to extract the value of Biofilm-Covered Area [%]. (A)–biofilm after treatment with antiseptic; (B,C)—processing stages aiming to extract the value of BCA [%]. Data collected with wide-field Lumascope 620, 20×, scale bare is 10 µm.
Figure 9. Processing of biofilm image to extract the value of Biofilm-Covered Area [%]. (A)–biofilm after treatment with antiseptic; (B,C)—processing stages aiming to extract the value of BCA [%]. Data collected with wide-field Lumascope 620, 20×, scale bare is 10 µm.
Ijms 23 13524 g009
Figure 10. ABE [%] value recorded for polyhexamethylene (PHMB), povidone–iodine (PVP-I) and hypochlorite solution (NaOCl) towards staphylococcal biofilms (n = 10) formed in vitro. ABE [%]—Antiseptic’s Biofilm Eradication. Letters a,b show statistically significant differences in ABE [%] values between PHMB and PVP-I vs. NaOCl. The red line represents the level of formation of non-treated, control biofilm in relation to which the loss of biofilm-covered area and fluorescence intensity in treated biofilms are calculated.
Figure 10. ABE [%] value recorded for polyhexamethylene (PHMB), povidone–iodine (PVP-I) and hypochlorite solution (NaOCl) towards staphylococcal biofilms (n = 10) formed in vitro. ABE [%]—Antiseptic’s Biofilm Eradication. Letters a,b show statistically significant differences in ABE [%] values between PHMB and PVP-I vs. NaOCl. The red line represents the level of formation of non-treated, control biofilm in relation to which the loss of biofilm-covered area and fluorescence intensity in treated biofilms are calculated.
Ijms 23 13524 g010
Figure 11. An attempt to explain the data presented in Table 1. Because of various cellular density between (A) and (B) parts of biofilm, the level of fluorescence of biofilm (B) is higher than that of biofilm (A), although biofilm (A) is thicker (4 “layers”) than biofilm (B), which consists of 3 “layers”. z1, z2—Z-axis showing biofilm thickness; green oval shapes—SYTO-9-dyed staphylococci emitting fluorescence; numbers in the central points of oval shapes show a higher number of cells in biofilm (A) in comparison to biofilm (B).
Figure 11. An attempt to explain the data presented in Table 1. Because of various cellular density between (A) and (B) parts of biofilm, the level of fluorescence of biofilm (B) is higher than that of biofilm (A), although biofilm (A) is thicker (4 “layers”) than biofilm (B), which consists of 3 “layers”. z1, z2—Z-axis showing biofilm thickness; green oval shapes—SYTO-9-dyed staphylococci emitting fluorescence; numbers in the central points of oval shapes show a higher number of cells in biofilm (A) in comparison to biofilm (B).
Ijms 23 13524 g011
Figure 12. Schematic presentation of the phenomena occurring during antiseptic activity against biofilm reflected in the formation of “holes” and in a drop in fluorescence intensity. For picture clarity sake, the staphylococcal cells are shown as cubes, while intact biofilm formed by the cells is presented as an even (with regard to height) structure. (1)—introduction of antiseptic agent to biofilm; (2) antiseptic agent activity; (3) destruction of cells (resulting from antiseptic agent activity) and removal of cells (resulting from antiseptic agent activity and rinsing). (A,C)—intact biofilm in 3D and -xy plane, respectively; (B,D)—biofilm after the application of antiseptic in 3D and -xy plane, respectively.
Figure 12. Schematic presentation of the phenomena occurring during antiseptic activity against biofilm reflected in the formation of “holes” and in a drop in fluorescence intensity. For picture clarity sake, the staphylococcal cells are shown as cubes, while intact biofilm formed by the cells is presented as an even (with regard to height) structure. (1)—introduction of antiseptic agent to biofilm; (2) antiseptic agent activity; (3) destruction of cells (resulting from antiseptic agent activity) and removal of cells (resulting from antiseptic agent activity and rinsing). (A,C)—intact biofilm in 3D and -xy plane, respectively; (B,D)—biofilm after the application of antiseptic in 3D and -xy plane, respectively.
Ijms 23 13524 g012
Table 1. The measured thickness of biofilm and the corresponding fluorescence level. A.U.—arbitrary units.
Table 1. The measured thickness of biofilm and the corresponding fluorescence level. A.U.—arbitrary units.
Thickness [µm]60.4834.5630.2469.12103.6838.88
Fluorescence [SYTO-9] A.U.104.780.579.2147.6178.664.9
Table 2. Main characteristics of staphylococcal biofilm in vitro cultured in this research.
Table 2. Main characteristics of staphylococcal biofilm in vitro cultured in this research.
Parameter(s)Characteristics
Confluency
shape
very high confluency. Rare areas non-covered with cells (“holes”)
the “hill-like” character
cellular densityhigher in the middle than in the top and bottom part of the biofilms.
distribution of “Live” and “Dead” cells
(a)
high share of “dead” cells in the bottom part of biofilms
(b)
high share of “live” cells in the middle part of biofilms
(c)
top part of biofilm may consist of a relatively equal number of “Live” and “Dead” cells or the share of “Dead” cells significantly exceeds the number of “Live” cells
thickness
(a)
high intra-species and individual variability.
(b)
areas of higher thickness not always display a higher fluorescence level comparing to areas of lower thickness
Table 3. Main preparative/process variables associated with the deviation in the obtained results and the suggested, counter-actions.
Table 3. Main preparative/process variables associated with the deviation in the obtained results and the suggested, counter-actions.
Parameter/Process/PhenomenonCharacteristicsAction
rinsing (liquid introduction/removal)randomly re-shapes biofilm architecture
(a)
perform with precaution;
(b)
if possible, standardize all sub-steps (place of pipette placement, force of liquid introduction/removal)
(c)
perform preliminary studies to check whether the number of rinsing steps may be reduced without compromising the quality of the performed analyses
(d)
due to rheological phenomena, the rim of the well and approximate region of pipette placement is of low usability for subsequent image processing
(e)
engage a single operator into the entire process of biofilm culturing, antiseptic introduction, and biofilm dyeing
PI dye is of lower applicability than SYTO-9PI dye is removed from the experimental setting to a higher extent than SYTO-9
(a)
consider the application of SYTO-9 only and compare the fluorescence level of SYTO-9-dyed biofilm treated with antiseptic to SYTO-9-dyed biofilm non-treated with antiseptic
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Krasowski, G.; Migdał, P.; Woroszyło, M.; Fijałkowski, K.; Chodaczek, G.; Czajkowska, J.; Dudek, B.; Nowicka, J.; Oleksy-Wawrzyniak, M.; Kwiek, B.; et al. The Assessment of Activity of Antiseptic Agents against Biofilm of Staphylococcus aureus Measured with the Use of Processed Microscopic Images. Int. J. Mol. Sci. 2022, 23, 13524. https://doi.org/10.3390/ijms232113524

AMA Style

Krasowski G, Migdał P, Woroszyło M, Fijałkowski K, Chodaczek G, Czajkowska J, Dudek B, Nowicka J, Oleksy-Wawrzyniak M, Kwiek B, et al. The Assessment of Activity of Antiseptic Agents against Biofilm of Staphylococcus aureus Measured with the Use of Processed Microscopic Images. International Journal of Molecular Sciences. 2022; 23(21):13524. https://doi.org/10.3390/ijms232113524

Chicago/Turabian Style

Krasowski, Grzegorz, Paweł Migdał, Marta Woroszyło, Karol Fijałkowski, Grzegorz Chodaczek, Joanna Czajkowska, Bartłomiej Dudek, Joanna Nowicka, Monika Oleksy-Wawrzyniak, Bartłomiej Kwiek, and et al. 2022. "The Assessment of Activity of Antiseptic Agents against Biofilm of Staphylococcus aureus Measured with the Use of Processed Microscopic Images" International Journal of Molecular Sciences 23, no. 21: 13524. https://doi.org/10.3390/ijms232113524

APA Style

Krasowski, G., Migdał, P., Woroszyło, M., Fijałkowski, K., Chodaczek, G., Czajkowska, J., Dudek, B., Nowicka, J., Oleksy-Wawrzyniak, M., Kwiek, B., Paleczny, J., Brożyna, M., & Junka, A. (2022). The Assessment of Activity of Antiseptic Agents against Biofilm of Staphylococcus aureus Measured with the Use of Processed Microscopic Images. International Journal of Molecular Sciences, 23(21), 13524. https://doi.org/10.3390/ijms232113524

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop